Finance News – Pfizer
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Pfizer boosts profit estimate, even as tariffs are absorbed and drug prices may be cut
Pfizer’s revised forecast indicates stronger earnings potential despite challenges from increased tariffs and possible reductions in medication costs, leading to positive investor...
Read Full Article →If AstraZeneca goes to the US, it will be a major blow for London and Labour
Relocating AstraZeneca's headquarters to the United States could significantly impact London’s financial markets and challenge the stability of current government plans supporting...
Read Full Article →Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting close...
Pharmaceutical companies are advancing the development of specialized cancer treatments, potentially reducing reliance on chemotherapy and driving significant market growth through...
Read Full Article →Pfizer and other drug companies make 'no commitments' to the White House on lower drug prices
Pfizer’s reluctance to guarantee reduced medication costs highlights ongoing challenges in achieving significant price cuts despite recent government efforts aimed at lowering expe...
Read Full Article →Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China
Pfizer has entered into an agreement potentially valued at $6 billion to distribute a cancer medication developed by 3SBio in international markets beyond China.
Read Full Article →European court sides with NYT over requests for von der Leyen’s texts with Pfizer CEO
The ruling may impact transparency in government communications and affect future access to documents related to pharmaceutical negotiations, potentially influencing public oversig...
Read Full Article →